Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of citalopram on chest pain in patients with functional chest pain
2021-002288-24Phase 4Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of citalopram in functional chest pain (FCP) and non-cardiac chest pain (NCCP), sponsored by Amsterdam University Medical Center. Primary endpoint: Global assessment of chest pain after 6 weeks. Started Jul 2021; status: terminated.
02
Drugs
citalopram
03
Conditions
functional chest pain (FCP)non-cardiac chest pain (NCCP)
Beyond the preview
Go deeper on 2021-002288-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002288-24.